Lepu Medical Technology (Beijing) Co., Ltd. (SWX:LEPU)
18.00
0.00 (0.00%)
At close: Nov 28, 2025
SWX:LEPU Revenue
Lepu Medical Technology (Beijing) had revenue of 1.57B CNY in the quarter ending September 30, 2025, with 11.97% growth. This brings the company's revenue in the last twelve months to 6.26B, down -3.84% year-over-year. In the year 2024, Lepu Medical Technology (Beijing) had annual revenue of 6.10B, down -23.52%.
Revenue (ttm)
6.26B CNY
Revenue Growth
-3.84%
P/S Ratio
4.76
Revenue / Employee
710.00K CNY
Employees
8,812
Market Cap
3.34B CHF
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.10B | -1.88B | -23.52% |
| Dec 31, 2023 | 7.98B | -2.63B | -24.78% |
| Dec 31, 2022 | 10.61B | -50.29M | -0.47% |
| Jan 1, 2022 | 10.66B | 2.62B | 32.61% |
| Dec 31, 2020 | 8.04B | 243.14M | 3.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nestlé | 90.90B |
| Roche Holding AG | 63.49B |
| Zurich Insurance Group AG | 55.44B |
| Novartis AG | 44.95B |
| UBS Group AG | 38.43B |
| Swiss Re AG | 34.59B |
| ABB Ltd | 27.52B |
| Holcim AG | 26.23B |